FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

773522000: Mogamulizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3723810016 Mogamulizumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3723811017 Mogamulizumab en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mogamulizumab Is a Substance with chemokine receptor antagonist mechanism of action true Inferred relationship Existential restriction modifier
Mogamulizumab Has disposition Antiviral false Inferred relationship Existential restriction modifier
Mogamulizumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Mogamulizumab Has disposition Chemokine receptor antagonist true Inferred relationship Existential restriction modifier
Mogamulizumab Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing mogamulizumab (medicinal product) Has active ingredient True Mogamulizumab Inferred relationship Existential restriction modifier 1
Product containing mogamulizumab in parenteral dose form (medicinal product form) Has active ingredient True Mogamulizumab Inferred relationship Existential restriction modifier 1
Mogamulizumab Has active ingredient True Mogamulizumab Inferred relationship Existential restriction modifier 1
Product containing only mogamulizumab in parenteral dose form (medicinal product form) Has active ingredient True Mogamulizumab Inferred relationship Existential restriction modifier 1
Poteligeo 20mg/5ml concentrate for solution for infusion vials (Kyowa Kirin Ltd) Has specific active ingredient True Mogamulizumab Inferred relationship Existential restriction modifier
Mogamulizumab 20mg/5ml solution for infusion vials Has specific active ingredient True Mogamulizumab Inferred relationship Existential restriction modifier
Mogamulizumab 20mg/5ml solution for infusion vials 1 vial Has specific active ingredient True Mogamulizumab Inferred relationship Existential restriction modifier
Poteligeo 20mg/5ml concentrate for solution for infusion vials (Kyowa Kirin Ltd) 1 vial Has specific active ingredient True Mogamulizumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start